Impact on Patients With Neuromuscular and Musculoskeletal Conditions Associated With Benign Chronic Pain Using Atlas Profilapxis
Atlasprofilax
2 other identifiers
interventional
20
1 country
1
Brief Summary
AtlasPROfilax®is a method performed in 2 authorized centers in Colombia focused on patients with chronic non-malignant pain. The study seeks to see the effectiveness of the method in different pathologies through a randomized double-blind study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable pain
Started Jan 2022
Longer than P75 for not_applicable pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2024
CompletedFirst Submitted
Initial submission to the registry
May 6, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2025
CompletedFirst Posted
Study publicly available on registry
August 4, 2026
CompletedAugust 4, 2026
January 1, 2026
2.4 years
May 6, 2025
July 29, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
pain reduction
Description: The patient is asked to rate their pain on a scale of 1 to 10. Scoring: 0: No pain. 1-3: Mild or slight pain. 4-6: Moderate pain. 7-10: Severe pain, the worst pain imaginable. Measurement will be taken on day 1, at 1 month, at 3 months, at 6 months, and at 12 months after the start of the intervention.
Baseline day 1, post treatment at 1 month post treatment , at 3 months post treatment , at 6 months post treatment, and at 12 months after the start of the intervention.
Secondary Outcomes (1)
fatigue severity scale
Baseline day 1, post treatment at 1 month post treatment , at 3 months post treatment , at 6 months post treatment, and at 12 months after the start of the intervention
Study Arms (2)
Atlasprofilax
EXPERIMENTALParticipants receive the Atlasprofilax therapy, performed using a certified mechanical device that delivers digitally controlled vibropressure stimulation to the suboccipital region, administered by trained personnel.
Sham Procedure
PLACEBO COMPARATORParticipants receive a sham procedure that mimics the Atlasprofilax intervention without delivering active vibropressure stimulation or therapeutic effect.
Interventions
The Sham Atlasprofilax Procedure is a non-therapeutic simulated procedure used as a placebo control. Participants undergo the same preparation, positioning, duration, and clinical setting as the experimental Atlasprofilax Therapy. The same device is applied to the suboccipital region; however, the device is deactivated or set to deliver no effective vibro-pressure, therapeutic frequency, or mechanical stimulation. This procedure is designed to have no neuromuscular or therapeutic effect and is used solely to maintain participant and assessor blindin
Atlasprofilax Therapy is a non-invasive neuromuscular procedure consisting of a single-session application of controlled vibro-pressure to specific points of the suboccipital region. The intervention is performed using a certified mechanical device that delivers digitally controlled percussive vibro-pressure at a predefined frequency and angle, without any manual manipulation of cervical vertebrae. The procedure aims to modulate neuromuscular and fascial tone in the cranio-cervical junction.
Eligibility Criteria
You may qualify if:
- Adults over the age of 18
- patient who consult the authorized Atlas care center
- patients with chronic non-malignant pain.
You may not qualify if:
- Inability to perform physical therapies.
- patient with pain neuropatict indiferent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fundacion Nacional Somoslead
- Cooperative University of Colombiacollaborator
Study Sites (1)
Bogota
Bogotá, Colombia
Related Publications (5)
Calvo-Lobo C, Unda-Solano F, Lopez-Lopez D, Sanz-Corbalan I, Romero-Morales C, Palomo-Lopez P, Seco-Calvo J, Rodriguez-Sanz D. Is pharmacologic treatment better than neural mobilization for cervicobrachial pain? A randomized clinical trial. Int J Med Sci. 2018 Mar 8;15(5):456-465. doi: 10.7150/ijms.23525. eCollection 2018.
PMID: 29559834BACKGROUNDHallgren RC, Greenman PE, Rechtien JJ. Atrophy of suboccipital muscles in patients with chronic pain: a pilot study. J Am Osteopath Assoc. 1994 Dec;94(12):1032-8.
PMID: 7852102BACKGROUNDMcPartland JM, Brodeur RR, Hallgren RC. Chronic neck pain, standing balance, and suboccipital muscle atrophy--a pilot study. J Manipulative Physiol Ther. 1997 Jan;20(1):24-9.
PMID: 9004119BACKGROUNDBasson CA, Stewart A, Mudzi W. The effect of neural mobilisation on cervico-brachial pain: design of a randomised controlled trial. BMC Musculoskelet Disord. 2014 Dec 10;15:419. doi: 10.1186/1471-2474-15-419.
PMID: 25492697BACKGROUNDCharras G, Yap AS. Tensile Forces and Mechanotransduction at Cell-Cell Junctions. Curr Biol. 2018 Apr 23;28(8):R445-R457. doi: 10.1016/j.cub.2018.02.003.
PMID: 29689229BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Hector Fabio Restrepo-Guerrero
FNS
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 6, 2025
First Posted
August 4, 2026
Study Start
January 1, 2022
Primary Completion
June 1, 2024
Study Completion
June 1, 2025
Last Updated
August 4, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share